# Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

> **NCT00264680** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 333 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** lamotrigine
- **DRUG:** valproic acid

## Key facts

- **NCT ID:** NCT00264680
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-01
- **Primary completion:** 2006-03-01
- **Final completion:** 2006-03-01
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2017-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264680, "Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00264680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*